WOLVERINE RESOURCES CORP. Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2025-02-28..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2025-02-28..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2025-02-28; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2025-02-28. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2025-02-28. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | (m) | |
| Stock-based compensation | (m) | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -424.22K USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2025-02-28 | (m) | (m) | (m) | $-424.22K | (m) | (m) | (m) | (m) | (m) |
| 2024-11-30 | (m) | (m) | (m) | $-465.94K | (m) | (m) | (m) | (m) | (m) |
| 2024-08-31 | (m) | (m) | (m) | $-433.25K | (m) | (m) | (m) | (m) | (m) |
| 2024-05-31 | (m) | (m) | (m) | $-389.65K | (m) | (m) | (m) | (m) | (m) |
| 2024-02-29 | (m) | (m) | (m) | $-344.62K | (m) | (m) | (m) | (m) | (m) |
| 2023-11-30 | (m) | (m) | (m) | $-374.98K | (m) | (m) | (m) | (m) | (m) |
| 2023-08-31 | (m) | (m) | (m) | $-387.16K | (m) | (m) | (m) | (m) | (m) |
| 2023-05-31 | (m) | (m) | (m) | $-333.49K | (m) | (m) | (m) | (m) | (m) |
| 2023-02-28 | (m) | (m) | (m) | $-337.00K | (m) | (m) | (m) | (m) | (m) |
| 2022-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-08-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-05-31 | (m) | (m) | (m) | $-3.40M | (m) | (m) | (m) | (m) | (m) |
| 2022-02-28 | (m) | (m) | (m) | $-3.39M | (m) | (m) | (m) | (m) | (m) |
| 2021-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-08-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-05-31 | (m) | (m) | (m) | $-161.39K | (m) | (m) | (m) | (m) | (m) |
| 2021-02-28 | (m) | (m) | (m) | $-167.87K | (m) | (m) | (m) | (m) | (m) |
| 2020-11-30 | (m) | (m) | (m) | $-197.80K | (m) | (m) | (m) | (m) | (m) |
| 2020-08-31 | (m) | (m) | (m) | $-218.58K | (m) | (m) | (m) | (m) | (m) |
| 2020-05-31 | (m) | (m) | (m) | $-253.03K | (m) | (m) | (m) | (m) | (m) |
| 2020-02-29 | (m) | (m) | (m) | $-241.26K | (m) | (m) | (m) | (m) | (m) |
| 2019-11-30 | (m) | (m) | (m) | $-222.38K | (m) | (m) | (m) | (m) | (m) |
| 2019-08-31 | (m) | (m) | (m) | $-249.27K | (m) | (m) | (m) | (m) | (m) |
| 2019-05-31 | (m) | (m) | (m) | $-233.53K | (m) | (m) | (m) | (m) | (m) |
| 2019-02-28 | (m) | (m) | (m) | $-249.12K | (m) | (m) | (m) | (m) | (m) |
| 2018-11-30 | (m) | (m) | (m) | $-305.21K | (m) | (m) | (m) | (m) | (m) |
| 2018-08-31 | (m) | (m) | (m) | $-270.00K | (m) | (m) | (m) | (m) | (m) |
| 2018-05-31 | (m) | (m) | (m) | $-268.59K | (m) | (m) | (m) | (m) | (m) |
| 2018-02-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-11-30 | (m) | (m) | (m) | $-216.53K | (m) | (m) | (m) | (m) | (m) |
| 2017-08-31 | (m) | (m) | (m) | $-240.13K | (m) | (m) | (m) | (m) | (m) |
| 2017-05-31 | (m) | (m) | (m) | $-286.16K | (m) | (m) | (m) | (m) | (m) |
| 2017-02-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-11-30 | (m) | (m) | (m) | $-312.69K | (m) | (m) | (m) | (m) | (m) |
| 2016-08-31 | (m) | (m) | (m) | $-324.71K | (m) | (m) | (m) | (m) | (m) |
| 2016-05-31 | (m) | (m) | (m) | $-370.25K | (m) | (m) | (m) | (m) | (m) |
| 2016-02-29 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-11-30 | (m) | (m) | (m) | $-494.79K | (m) | (m) | (m) | (m) | (m) |
| 2015-08-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-05-31 | (m) | (m) | (m) | $-594.97K | (m) | (m) | (m) | (m) | (m) |
| 2015-02-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-11-30 | (m) | (m) | (m) | $-430.04K | (m) | (m) | (m) | (m) | (m) |
| 2014-05-31 | (m) | (m) | (m) | $-262.57K | (m) | (m) | (m) | (m) | (m) |
| 2014-02-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-11-30 | (m) | $0.00 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-08-31 | (m) | $0.00 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-05-31 | (m) | $0.00 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-02-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-08-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-05-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-02-29 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-02-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-08-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-05-31 | (m) | $0.00 | $0.00 | $-686.15K | (m) | (m) | (m) | (m) | (m) |
| 2011-02-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-08-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.